| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aminopeptidase activity | 9.12e-05 | 43 | 110 | 4 | GO:0004177 | |
| GeneOntologyMolecularFunction | RNA polymerase core enzyme binding | 1.09e-04 | 45 | 110 | 4 | GO:0043175 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 1.19e-04 | 46 | 110 | 4 | GO:0030020 | |
| GeneOntologyMolecularFunction | metalloaminopeptidase activity | 3.86e-04 | 26 | 110 | 3 | GO:0070006 | |
| GeneOntologyMolecularFunction | RNA polymerase binding | 4.56e-04 | 65 | 110 | 4 | GO:0070063 | |
| GeneOntologyMolecularFunction | basal RNA polymerase II transcription machinery binding | 4.83e-04 | 66 | 110 | 4 | GO:0001099 | |
| GeneOntologyMolecularFunction | basal transcription machinery binding | 4.83e-04 | 66 | 110 | 4 | GO:0001098 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 6.12e-04 | 188 | 110 | 6 | GO:0005201 | |
| GeneOntologyCellularComponent | collagen type VI trimer | 8.35e-05 | 3 | 111 | 2 | GO:0005589 | |
| GeneOntologyCellularComponent | collagen beaded filament | 8.35e-05 | 3 | 111 | 2 | GO:0098647 | |
| HumanPheno | Quadriceps muscle weakness | 1.69e-05 | 23 | 36 | 4 | HP:0003731 | |
| Domain | VWA | 1.86e-05 | 56 | 109 | 5 | PF00092 | |
| Domain | VWF_A | 2.48e-05 | 99 | 109 | 6 | IPR002035 | |
| Domain | Peptidase_M1 | 4.09e-05 | 12 | 109 | 3 | IPR001930 | |
| Domain | Peptidase_M1_N | 5.30e-05 | 13 | 109 | 3 | IPR014782 | |
| Domain | Peptidase_M1 | 5.30e-05 | 13 | 109 | 3 | PF01433 | |
| Domain | VWFA | 1.18e-04 | 82 | 109 | 5 | PS50234 | |
| Domain | VWA | 1.32e-04 | 84 | 109 | 5 | SM00327 | |
| Domain | ConA-like_dom | 3.00e-04 | 219 | 109 | 7 | IPR013320 | |
| Domain | Laminin_G | 3.65e-04 | 58 | 109 | 4 | IPR001791 | |
| Domain | ERAP1-like_C_dom | 9.24e-04 | 8 | 109 | 2 | IPR024571 | |
| Domain | ERAP1_C | 9.24e-04 | 8 | 109 | 2 | PF11838 | |
| Domain | Collagen | 1.55e-03 | 85 | 109 | 4 | IPR008160 | |
| Domain | Collagen | 1.55e-03 | 85 | 109 | 4 | PF01391 | |
| Domain | LamG | 2.15e-03 | 44 | 109 | 3 | SM00282 | |
| Domain | - | 2.32e-03 | 95 | 109 | 4 | 2.60.120.200 | |
| Domain | uDENN | 2.93e-03 | 14 | 109 | 2 | SM00800 | |
| Domain | uDENN | 3.37e-03 | 15 | 109 | 2 | PF03456 | |
| Domain | DENN | 3.84e-03 | 16 | 109 | 2 | SM00799 | |
| Domain | DENN | 3.84e-03 | 16 | 109 | 2 | PF02141 | |
| Domain | dDENN | 3.84e-03 | 16 | 109 | 2 | PF03455 | |
| Domain | UDENN | 3.84e-03 | 16 | 109 | 2 | PS50946 | |
| Domain | DDENN | 3.84e-03 | 16 | 109 | 2 | PS50947 | |
| Domain | dDENN | 3.84e-03 | 16 | 109 | 2 | SM00801 | |
| Domain | dDENN_dom | 3.84e-03 | 16 | 109 | 2 | IPR005112 | |
| Domain | uDENN_dom | 3.84e-03 | 16 | 109 | 2 | IPR005113 | |
| Domain | DENN | 3.84e-03 | 16 | 109 | 2 | PS50211 | |
| Domain | DENN_dom | 3.84e-03 | 16 | 109 | 2 | IPR001194 | |
| Domain | Integrin_alpha-2 | 4.86e-03 | 18 | 109 | 2 | IPR013649 | |
| Domain | INTEGRIN_ALPHA | 4.86e-03 | 18 | 109 | 2 | PS00242 | |
| Domain | Integrin_alpha2 | 4.86e-03 | 18 | 109 | 2 | PF08441 | |
| Domain | Integrin_alpha | 4.86e-03 | 18 | 109 | 2 | IPR000413 | |
| Domain | Int_alpha | 5.41e-03 | 19 | 109 | 2 | SM00191 | |
| Domain | Int_alpha_beta-p | 5.41e-03 | 19 | 109 | 2 | IPR013519 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 2.81e-08 | 85 | 81 | 8 | M16441 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 2.52e-07 | 76 | 81 | 7 | MM14867 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 5.41e-05 | 300 | 81 | 9 | M610 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 7.42e-05 | 76 | 81 | 5 | M27219 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 8.71e-05 | 41 | 81 | 4 | MM15538 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.15e-04 | 258 | 81 | 8 | MM14572 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 1.15e-04 | 44 | 81 | 4 | M27812 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 1.20e-04 | 84 | 81 | 5 | M7098 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.50e-04 | 47 | 81 | 4 | MM14925 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.52e-04 | 140 | 81 | 6 | M587 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.94e-04 | 20 | 81 | 3 | MM15061 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 4.12e-04 | 61 | 81 | 4 | MM14637 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 4.95e-04 | 64 | 81 | 4 | M26953 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 5.56e-04 | 66 | 81 | 4 | M18 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 5.89e-04 | 67 | 81 | 4 | M26999 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 2.76e-07 | 135 | 111 | 7 | 28675934 | |
| Pubmed | Differential and restricted expression of novel collagen VI chains in mouse. | 3.15e-07 | 5 | 111 | 3 | 21477648 | |
| Pubmed | The expanded collagen VI family: new chains and new questions. | 3.15e-07 | 5 | 111 | 3 | 23869615 | |
| Pubmed | 4.69e-07 | 146 | 111 | 7 | 27068509 | ||
| Pubmed | Three novel collagen VI chains with high homology to the alpha3 chain. | 1.10e-06 | 7 | 111 | 3 | 18276594 | |
| Pubmed | Three novel collagen VI chains, alpha4(VI), alpha5(VI), and alpha6(VI). | 1.10e-06 | 7 | 111 | 3 | 18400749 | |
| Pubmed | 1.58e-06 | 175 | 111 | 7 | 28071719 | ||
| Pubmed | A mouse model for dominant collagen VI disorders: heterozygous deletion of Col6a3 Exon 16. | 1.75e-06 | 8 | 111 | 3 | 24563484 | |
| Pubmed | 1.98e-06 | 64 | 111 | 5 | 22261194 | ||
| Pubmed | NRDE2 DENND4A VTN POLE SREBF2 DOCK10 PAPSS2 TYK2 GTF2F1 TRMT2A MID1 | 7.80e-06 | 650 | 111 | 11 | 38777146 | |
| Pubmed | 8.29e-06 | 225 | 111 | 7 | 12168954 | ||
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 8.57e-06 | 86 | 111 | 5 | 28327460 | |
| Pubmed | 9.07e-06 | 87 | 111 | 5 | 12465718 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 32389683 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 21364666 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 11120819 | ||
| Pubmed | Bethlem myopathy: a series of 16 patients and description of seven new associated mutations. | 1.01e-05 | 2 | 111 | 2 | 30706156 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 33188786 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 26824076 | ||
| Pubmed | Stromal Integrin α11β1 Affects RM11 Prostate and 4T1 Breast Xenograft Tumors Differently. | 1.01e-05 | 2 | 111 | 2 | 26990302 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 17947699 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 15070758 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 27377666 | ||
| Pubmed | Absence of T and B lymphocytes modulates dystrophic features in dysferlin deficient animal model. | 1.01e-05 | 2 | 111 | 2 | 22465227 | |
| Pubmed | 1.67e-05 | 167 | 111 | 6 | 22159717 | ||
| Pubmed | 1.72e-05 | 16 | 111 | 3 | 16880404 | ||
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 2.26e-05 | 363 | 111 | 8 | 14691545 | |
| Pubmed | Mosaicism for dominant collagen 6 mutations as a cause for intrafamilial phenotypic variability. | 3.02e-05 | 3 | 111 | 2 | 25204870 | |
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 21459131 | ||
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 36982625 | ||
| Pubmed | Amino acid sequence of the triple-helical domain of human collagen type VI. | 3.02e-05 | 3 | 111 | 2 | 3198591 | |
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 8489506 | ||
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 26148229 | ||
| Pubmed | Exon skipping mutations in collagen VI are common and are predictive for severity and inheritance. | 3.02e-05 | 3 | 111 | 2 | 18366090 | |
| Pubmed | Mixed lineage kinase LZK and antioxidant protein-1 activate NF-kappaB synergistically. | 3.02e-05 | 3 | 111 | 2 | 12492477 | |
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 24801232 | ||
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 16141002 | ||
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 7780011 | ||
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 20301676 | ||
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 23500679 | ||
| Pubmed | Type VI collagen mutations in Bethlem myopathy, an autosomal dominant myopathy with contractures. | 3.02e-05 | 3 | 111 | 2 | 8782832 | |
| Pubmed | Collagen VI involvement in Ullrich syndrome: a clinical, genetic, and immunohistochemical study. | 3.02e-05 | 3 | 111 | 2 | 12011280 | |
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 9632806 | ||
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 3665927 | ||
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 24443028 | ||
| Pubmed | Dominant collagen VI mutations are a common cause of Ullrich congenital muscular dystrophy. | 3.02e-05 | 3 | 111 | 2 | 15563506 | |
| Pubmed | Expression of type VI collagen in the developing mouse heart. | 3.02e-05 | 3 | 111 | 2 | 9520112 | |
| Pubmed | Cloning and chromosomal localization of human genes encoding the three chains of type VI collagen. | 3.02e-05 | 3 | 111 | 2 | 3348212 | |
| Pubmed | 4.47e-05 | 199 | 111 | 6 | 23382691 | ||
| Pubmed | 4.66e-05 | 22 | 111 | 3 | 8673525 | ||
| Pubmed | Effect of various glycosidase treatments on the resistance of the HIV-1 envelope to degradation. | 4.66e-05 | 22 | 111 | 3 | 9109416 | |
| Pubmed | 4.66e-05 | 22 | 111 | 3 | 11530211 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | VWA5B2 MON2 HSPG2 MAN2A2 POLE DYSF TYK2 PCNX2 AATK PAXIP1 PRKDC WDFY3 DNMBP | 5.29e-05 | 1105 | 111 | 13 | 35748872 |
| Pubmed | 5.35e-05 | 23 | 111 | 3 | 1736542 | ||
| Pubmed | 5.35e-05 | 23 | 111 | 3 | 8093218 | ||
| Pubmed | Glycosylation inhibitors block the expression of LAV/HTLV-III (HIV) glycoproteins. | 5.35e-05 | 23 | 111 | 3 | 3099781 | |
| Pubmed | Role of protein N-glycosylation in pathogenesis of human immunodeficiency virus type 1. | 5.35e-05 | 23 | 111 | 3 | 3264072 | |
| Pubmed | 6.03e-05 | 4 | 111 | 2 | 16270321 | ||
| Pubmed | 6.03e-05 | 4 | 111 | 2 | 22392992 | ||
| Pubmed | 6.03e-05 | 4 | 111 | 2 | 8806434 | ||
| Pubmed | 6.03e-05 | 4 | 111 | 2 | 26311161 | ||
| Pubmed | 6.03e-05 | 4 | 111 | 2 | 36759517 | ||
| Pubmed | 6.03e-05 | 4 | 111 | 2 | 26831100 | ||
| Pubmed | 6.03e-05 | 4 | 111 | 2 | 18761340 | ||
| Pubmed | Deficiency of tenascin-X causes a decrease in the level of expression of type VI collagen. | 6.03e-05 | 4 | 111 | 2 | 15194424 | |
| Pubmed | Perlecan regulates pericyte dynamics in the maintenance and repair of the blood-brain barrier. | 8.75e-05 | 27 | 111 | 3 | 31541017 | |
| Pubmed | 1.00e-04 | 5 | 111 | 2 | 31932854 | ||
| Pubmed | IκB Kinase α Is Required for Development and Progression of KRAS-Mutant Lung Adenocarcinoma. | 1.00e-04 | 5 | 111 | 2 | 29588349 | |
| Pubmed | 1.33e-04 | 31 | 111 | 3 | 12171929 | ||
| Pubmed | 1.36e-04 | 153 | 111 | 5 | 25037231 | ||
| Pubmed | 1.50e-04 | 6 | 111 | 2 | 30214937 | ||
| Pubmed | 1.50e-04 | 6 | 111 | 2 | 14704337 | ||
| Pubmed | 1.50e-04 | 6 | 111 | 2 | 15613478 | ||
| Pubmed | Developmental regulation of biglycan expression in muscle and tendon. | 1.50e-04 | 6 | 111 | 2 | 16810681 | |
| Pubmed | Phosphorylation of CARMA1 by HPK1 is critical for NF-kappaB activation in T cells. | 1.50e-04 | 6 | 111 | 2 | 19706536 | |
| Pubmed | 1.50e-04 | 6 | 111 | 2 | 14966265 | ||
| Pubmed | 1.50e-04 | 6 | 111 | 2 | 10089886 | ||
| Pubmed | 2.10e-04 | 7 | 111 | 2 | 38788720 | ||
| Pubmed | PDK1 nucleates T cell receptor-induced signaling complex for NF-kappaB activation. | 2.10e-04 | 7 | 111 | 2 | 15802604 | |
| Pubmed | 2.10e-04 | 7 | 111 | 2 | 12242711 | ||
| Pubmed | 2.27e-04 | 37 | 111 | 3 | 2541446 | ||
| Pubmed | 2.27e-04 | 37 | 111 | 3 | 19430480 | ||
| Pubmed | 2.46e-04 | 38 | 111 | 3 | 2829950 | ||
| Pubmed | 2.46e-04 | 38 | 111 | 3 | 25572963 | ||
| Pubmed | Characterization of the secreted, native gp120 and gp160 of the human immunodeficiency virus type 1. | 2.46e-04 | 38 | 111 | 3 | 2187500 | |
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 2.71e-04 | 97 | 111 | 4 | 27559042 | |
| Pubmed | 2.79e-04 | 8 | 111 | 2 | 29946151 | ||
| Pubmed | 2.79e-04 | 8 | 111 | 2 | 15723802 | ||
| Pubmed | Fras1 deficiency results in cryptophthalmos, renal agenesis and blebbed phenotype in mice. | 2.79e-04 | 8 | 111 | 2 | 12766770 | |
| Pubmed | 2.87e-04 | 40 | 111 | 3 | 16210410 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 2.98e-04 | 398 | 111 | 7 | 35016035 | |
| Pubmed | Proteomics characterization of extracellular space components in the human aorta. | 3.16e-04 | 101 | 111 | 4 | 20551380 | |
| Pubmed | 3.58e-04 | 9 | 111 | 2 | 12080061 | ||
| Pubmed | Common genetic variation at the IL1RL1 locus regulates IL-33/ST2 signaling. | 3.58e-04 | 9 | 111 | 2 | 23999434 | |
| Pubmed | Glycosylation and processing of the human immunodeficiency virus type 1 envelope protein. | 4.35e-04 | 46 | 111 | 3 | 2649653 | |
| Pubmed | 4.47e-04 | 10 | 111 | 2 | 20164171 | ||
| Pubmed | 4.47e-04 | 10 | 111 | 2 | 11386760 | ||
| Pubmed | The extracellular matrix gene Frem1 is essential for the normal adhesion of the embryonic epidermis. | 4.47e-04 | 10 | 111 | 2 | 15345741 | |
| Pubmed | 5.45e-04 | 11 | 111 | 2 | 21782286 | ||
| Pubmed | 5.56e-04 | 50 | 111 | 3 | 23658023 | ||
| GeneFamily | Collagens | 3.91e-05 | 46 | 75 | 4 | 490 | |
| GeneFamily | Aminopeptidases|CD molecules | 4.47e-05 | 17 | 75 | 3 | 104 | |
| GeneFamily | Mannosyl-glycoprotein N-acetylglucosaminyltransferases | 6.00e-04 | 9 | 75 | 2 | 435 | |
| GeneFamily | Olfactory receptors, family 56 | 6.00e-04 | 9 | 75 | 2 | 167 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 2.49e-03 | 18 | 75 | 2 | 1160 | |
| GeneFamily | G protein-coupled receptors, Class A orphans | 4.17e-03 | 78 | 75 | 3 | 262 | |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 4.79e-03 | 25 | 75 | 2 | 504 | |
| Coexpression | NABA_CORE_MATRISOME | 2.31e-06 | 270 | 111 | 9 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 2.69e-06 | 275 | 111 | 9 | M5884 | |
| Coexpression | GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_HET_2H_DN | 2.28e-05 | 199 | 111 | 7 | M8709 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 2.47e-05 | 40 | 111 | 4 | M5887 | |
| Coexpression | NABA_COLLAGENS | 3.31e-05 | 43 | 111 | 4 | MM17060 | |
| Coexpression | NABA_COLLAGENS | 3.63e-05 | 44 | 111 | 4 | M3005 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.00e-07 | 176 | 111 | 7 | 852d3da0907fe87c0ef23d75a63ce07619cf0c54 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.00e-07 | 176 | 111 | 7 | d2df1e435996c51213e88270af9f928e9e09a6f5 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-07 | 179 | 111 | 7 | e880c507f11ce75d104593a4ca29f0295f8125e8 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-OPC_related|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.24e-06 | 137 | 111 | 6 | 264d5e06c37d1a9ef7748091b67d2a5aa803096e | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-OPC_related-Oligodendrocyte/OPC|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.24e-06 | 137 | 111 | 6 | 8ce463d1d74ac0ce80b812217d6bd76a788f14d2 | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l21|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.06e-06 | 168 | 111 | 6 | 6c758eb120faf06ff72d157b495e399191c79ec9 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.97e-06 | 174 | 111 | 6 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 7.27e-06 | 186 | 111 | 6 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 8.46e-06 | 191 | 111 | 6 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Cervical_Squamous_Cell_Carcinoma-6|TCGA-Cervix / Sample_Type by Project: Shred V9 | 8.69e-06 | 111 | 111 | 5 | 45a8e069369fdc7358135bf2229defbee1ac2600 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.98e-06 | 193 | 111 | 6 | 64edc1d6fb0fe117767d494cf4a5723bf8be2804 | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.04e-05 | 198 | 111 | 6 | 4f4632f26a2043c5e4ab89031b4229b5dca1bd48 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.07e-05 | 199 | 111 | 6 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.10e-05 | 200 | 111 | 6 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.10e-05 | 200 | 111 | 6 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.10e-05 | 200 | 111 | 6 | 50ca6550998e461ef26dd670351060bd940765a8 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.10e-05 | 200 | 111 | 6 | 44a68bacdb3d5bf563bd35952176995850933a81 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.10e-05 | 200 | 111 | 6 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.10e-05 | 200 | 111 | 6 | dc61016c61729f69649cfb21f6264e685ce83dea | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-05 | 138 | 111 | 5 | 19ffd66256fa94d728138d37d0a5a3bac7722dbb | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-05 | 138 | 111 | 5 | 321070b6900887b27da0f2b25808a05a8ab89ee7 | |
| ToppCell | facs-SCAT-Fat-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.34e-05 | 155 | 111 | 5 | 93513bab53b40e9c3c91ab8e3316ea00a4f66cd2 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.34e-05 | 155 | 111 | 5 | 8fdda4e3657ac56188ae88ed3caf145f4d9d1567 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c13-HAVCR2|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.76e-05 | 158 | 111 | 5 | a38345ffc5a7576ce99212bcbd620864a19de1fc | |
| ToppCell | severe-unassigned|World / disease stage, cell group and cell class | 5.68e-05 | 164 | 111 | 5 | b3a45c150df6594debeeca400cc58d30ef662756 | |
| ToppCell | severe-unassigned|severe / disease stage, cell group and cell class | 5.85e-05 | 165 | 111 | 5 | f9ddd547992fec065d539a1d0305acba8fc7d79c | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_D3|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.85e-05 | 165 | 111 | 5 | a379fa981db51bec01adea7b1e55e133e15ec383 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte-Chondrocyte_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.02e-05 | 166 | 111 | 5 | 37794a84601a2a949d579663d4a4bb8bc8fb5923 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.02e-05 | 166 | 111 | 5 | 81c546c6d847e49e662b81e71992ca0f7a99e890 | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-Regulatory_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.37e-05 | 168 | 111 | 5 | 1df3c8c7a6dceb901805eaba7f86f9943f4f1a9d | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-I_cells_(CCK+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.37e-05 | 168 | 111 | 5 | f3164a85e5630ee8a745c6dba298e1f94ba4d5b8 | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-regulatory_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.37e-05 | 168 | 111 | 5 | 1586451d437b70b2dffe41d782b694702dcaf50b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.92e-05 | 171 | 111 | 5 | 2a34685f7d83d1cf9a88d304173cbca868c5f9fd | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-intermediate_neuroendocrine|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.92e-05 | 171 | 111 | 5 | b7cddb8f726a43fb8a37f3e67a3f722e2178fd7a | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l15|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.12e-05 | 172 | 111 | 5 | de4961f4037c439d3e0ec706a257b0ec17f4d5be | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-05 | 172 | 111 | 5 | 3f784aed340b50ddbec3f7dc0a5279180d38a2bb | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-neuro-epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.31e-05 | 173 | 111 | 5 | 30fa8c14c8a1f546f380132c0c28a61e6a2f9fc4 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_GPR21|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.52e-05 | 174 | 111 | 5 | 0df738309b7b6e77675ea74e7a87e66601b0073d | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.72e-05 | 175 | 111 | 5 | 182e45f5c02214d6b9f317ff5dc43af8b42de978 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_GPR21|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.93e-05 | 176 | 111 | 5 | ed7ba2a3af3b060dec98b60f09f96000a67f7e63 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.93e-05 | 176 | 111 | 5 | 5e46a09a36b9645b1b1fcb0b64bd0898561af3a9 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.15e-05 | 177 | 111 | 5 | f902600c639087664316b3cf30cab243bc3d1c5c | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-D_cells_(SST+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.15e-05 | 177 | 111 | 5 | 8dbef0005095c01a806d8c7f723dc48a4650efec | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.15e-05 | 177 | 111 | 5 | 14fb8d182775dfd0e49aa7e4e12543a85b3b8bd6 | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.37e-05 | 178 | 111 | 5 | 8591a40fced747ac16b3e8ebc7a22dfb3ad76da2 | |
| ToppCell | Ciliated_cells-A-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 8.37e-05 | 178 | 111 | 5 | 255473ee6df8a13079fb3bb61038162a40cb4c2c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.59e-05 | 179 | 111 | 5 | 8766a5a066091879f521acfc612abf563ff78808 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.05e-05 | 181 | 111 | 5 | 30729f0364f719c044712a51453e22dc2c1a232b | |
| ToppCell | facs-Large_Intestine-Distal-24m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.29e-05 | 182 | 111 | 5 | 398ce074a04f6482470b488f1affae4af7d2ec58 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.29e-05 | 182 | 111 | 5 | bc8d621be57f76d718d9b0f11e023b0f4dcb668d | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.53e-05 | 183 | 111 | 5 | 5377b4fbd8fdfe68933b4c0965aa9525f7f31591 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-Cd4_positive_Macrophages|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.53e-05 | 183 | 111 | 5 | 92ef926e6c1de8477fa4f35d1dae85482d8009de | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.53e-05 | 183 | 111 | 5 | 24db9cc717e651586317c6a8e03a3401651273c1 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.78e-05 | 184 | 111 | 5 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 1.00e-04 | 185 | 111 | 5 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neuron_precursor-cycling_neuroblast|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.03e-04 | 186 | 111 | 5 | 4fe8e0bf74c7dbf73634cafdacad89020d2634d0 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.05e-04 | 187 | 111 | 5 | f3e37c18ac6471c7992609bbddfa4975571c815c | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.08e-04 | 188 | 111 | 5 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.11e-04 | 189 | 111 | 5 | 3169476f98b7385706cb618c9ad64ae83a290ef0 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 190 | 111 | 5 | bfbdf16d488359d7935a419c4c1823288f39c183 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 190 | 111 | 5 | eb1f8bb4d903b08e50c2dc173b06c0c79d8e316e | |
| ToppCell | NS-control-d_0-4-Lymphoid-CTL|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.16e-04 | 191 | 111 | 5 | 27f2151da2f41015a979499f274ab1284a36189f | |
| ToppCell | control-Lymphoid-CTL|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.16e-04 | 191 | 111 | 5 | 8df23473e24cfa51c09986102ddd391ed0f0b9cc | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-Myofibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.16e-04 | 191 | 111 | 5 | aa43b472bc8362f79ae63f09f1ca764718bbf22c | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 192 | 111 | 5 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 192 | 111 | 5 | a2c31390da4962bda9a936470b0b68fa1f5d47d1 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 192 | 111 | 5 | 8937a59f6bbe07f671bdabbd3707dc9c17a14cd9 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 192 | 111 | 5 | eeab1cef7c36ae824381952c5b2c982368c379fd | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 192 | 111 | 5 | e4a7f2673f801b008ca67291db2fb2b9fd2955b8 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.19e-04 | 192 | 111 | 5 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.19e-04 | 192 | 111 | 5 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 192 | 111 | 5 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 192 | 111 | 5 | ac1477433704573f95111eee6263b93668d2845e | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 192 | 111 | 5 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell|Adult / Lineage, Cell type, age group and donor | 1.19e-04 | 192 | 111 | 5 | d21f0f577156f17c899b08871046a26b88aea011 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma-early_osteoblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.22e-04 | 193 | 111 | 5 | 5e46a9f65e85aca78f825fdef88a95b97eec8743 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 193 | 111 | 5 | 428b1a3ad87dff7f65de5161d40f102572a9341b | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.22e-04 | 193 | 111 | 5 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.25e-04 | 194 | 111 | 5 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.25e-04 | 194 | 111 | 5 | af4bbb2deb5a3913eb58990690fc3c62fbc3708c | |
| ToppCell | droplet-Bladder-Unstain-18m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 195 | 111 | 5 | 841fde528ecb293e07b5e00e499d1e9f0b0dce14 | |
| ToppCell | ASK428-Mesenchymal|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.28e-04 | 195 | 111 | 5 | 2b156163975d9a3d3fda1402acd9831d0fdc9e25 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.28e-04 | 195 | 111 | 5 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | ASK428-Mesenchymal-Fibroblast|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.28e-04 | 195 | 111 | 5 | c269c0d894a0f55da6495b59d4b9abb9f68df684 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 195 | 111 | 5 | 095b8e0be385b6390420589124a95fa4ba3682ab | |
| ToppCell | facs-Thymus-Thymus_Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 196 | 111 | 5 | 6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 196 | 111 | 5 | c8c89e469402e11aa2a9561e859b6fd1fb66c39b | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.31e-04 | 196 | 111 | 5 | df366d76ea55f49e349d622effa57c1535df8400 | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.31e-04 | 196 | 111 | 5 | 028a06ed92f1c058dcbeacd335625bf529e87a7b | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.31e-04 | 196 | 111 | 5 | 95544097577f20ed7f4144bd940471cde0617554 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 196 | 111 | 5 | f47e551ba484687ba6ce8c29a085106131364042 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.31e-04 | 196 | 111 | 5 | 275e153347caf94edc0c50021bbab49c8696fecb | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.35e-04 | 197 | 111 | 5 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-04 | 197 | 111 | 5 | 86145bc1e585b4ae136e755cafd6579da2abfa65 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 1.38e-04 | 198 | 111 | 5 | 0c4d2c68a42f8a9e964e2dd28092fe75f5216834 | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-immature_Neutrophil|COVID-19_Mild / Disease, condition lineage and cell class | 1.41e-04 | 199 | 111 | 5 | e222b90caf45904d8f763574e7b6aac13333df92 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 1.41e-04 | 199 | 111 | 5 | c2c42ecf20d1924edc2f899c01dfa5fcf3c210b9 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.41e-04 | 199 | 111 | 5 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.41e-04 | 199 | 111 | 5 | 2cec0e370ee9bb3c88a7acb5519e9ea8ddb399bc | |
| ToppCell | droplet-Trachea|droplet / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 199 | 111 | 5 | 1c7d30765ddb2291967da5d15664c6238c680c1d | |
| Drug | losartan | HSPG2 COL6A1 COL6A3 ITGA11 COL16A1 ATCAY ACTBL2 ITGAD ABCC6 SLC9A2 PRKCQ | 2.45e-06 | 378 | 111 | 11 | CID000003961 |
| Drug | Sulfacetamide sodic hydrate [6209-17-2]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 5.41e-06 | 196 | 111 | 8 | 1695_DN | |
| Disease | calpastatin measurement | 2.56e-06 | 8 | 107 | 3 | EFO_0008065 | |
| Disease | Ullrich congenital muscular dystrophy (implicated_via_orthology) | 1.30e-05 | 2 | 107 | 2 | DOID:0050558 (implicated_via_orthology) | |
| Disease | complement factor D measurement | 2.30e-05 | 93 | 107 | 5 | EFO_0020283 | |
| Disease | Ullrich congenital muscular dystrophy | 7.78e-05 | 4 | 107 | 2 | cv:C4551860 | |
| Disease | Bethlem myopathy | 7.78e-05 | 4 | 107 | 2 | cv:C1834674 | |
| Disease | BETHLEM MYOPATHY 1 | 7.78e-05 | 4 | 107 | 2 | C1834674 | |
| Disease | Ullrich congenital muscular dystrophy 1 | 7.78e-05 | 4 | 107 | 2 | C0410179 | |
| Disease | Bethlem myopathy (is_implicated_in) | 7.78e-05 | 4 | 107 | 2 | DOID:0050663 (is_implicated_in) | |
| Disease | Ullrich congenital muscular dystrophy (is_implicated_in) | 7.78e-05 | 4 | 107 | 2 | DOID:0050558 (is_implicated_in) | |
| Disease | age-related macular degeneration, COVID-19 | 1.18e-04 | 69 | 107 | 4 | EFO_0001365, MONDO_0100096 | |
| Disease | congenital muscular dystrophy (implicated_via_orthology) | 1.94e-04 | 6 | 107 | 2 | DOID:0050557 (implicated_via_orthology) | |
| Disease | calcipressin-1 measurement | 2.70e-04 | 7 | 107 | 2 | EFO_0801442 | |
| Disease | poly(A) RNA polymerase, mitochondrial measurement | 3.60e-04 | 8 | 107 | 2 | EFO_0801893 | |
| Disease | Adenocarcinoma of large intestine | 4.20e-04 | 96 | 107 | 4 | C1319315 | |
| Disease | interferon alpha/beta receptor 1 measurement | 4.61e-04 | 9 | 107 | 2 | EFO_0021850 | |
| Disease | colorectal cancer, endometrial neoplasm | 4.80e-04 | 42 | 107 | 3 | EFO_0004230, MONDO_0005575 | |
| Disease | Crohn's disease of large bowel | 5.51e-04 | 44 | 107 | 3 | C0156147 | |
| Disease | IIeocolitis | 5.51e-04 | 44 | 107 | 3 | C0949272 | |
| Disease | Crohn's disease of the ileum | 5.51e-04 | 44 | 107 | 3 | C0267380 | |
| Disease | Regional enteritis | 5.51e-04 | 44 | 107 | 3 | C0678202 | |
| Disease | adult onset asthma, body mass index | 5.75e-04 | 10 | 107 | 2 | EFO_0004340, EFO_1002011 | |
| Disease | interleukin 1 receptor-like 1 measurement | 7.01e-04 | 11 | 107 | 2 | EFO_0008168 | |
| Disease | serum ST2 measurement | 7.01e-04 | 11 | 107 | 2 | EFO_0005416 | |
| Disease | 3-hydroxyanthranilate 3,4-dioxygenase measurement | 7.01e-04 | 11 | 107 | 2 | EFO_0021862 | |
| Disease | Crohn Disease | 8.03e-04 | 50 | 107 | 3 | C0010346 | |
| Disease | adult onset asthma | 9.13e-04 | 118 | 107 | 4 | EFO_1002011 | |
| Disease | interleukin 18 receptor 1 measurement | 1.33e-03 | 15 | 107 | 2 | EFO_0008178 | |
| Disease | neutrophil collagenase measurement | 1.51e-03 | 16 | 107 | 2 | EFO_0008248 | |
| Disease | muscular dystrophy (is_implicated_in) | 1.71e-03 | 17 | 107 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | alpha-L-iduronidase measurement | 1.71e-03 | 17 | 107 | 2 | EFO_0020139 | |
| Disease | disease free survival | 1.92e-03 | 18 | 107 | 2 | EFO_0000409 | |
| Disease | Central precocious puberty | 2.14e-03 | 19 | 107 | 2 | EFO_0009029 | |
| Disease | COVID-19, osteoarthritis | 2.37e-03 | 20 | 107 | 2 | MONDO_0005178, MONDO_0100096 | |
| Disease | urinary microalbumin measurement | 2.37e-03 | 20 | 107 | 2 | EFO_0010967 | |
| Disease | lymphocyte percentage of leukocytes | 2.95e-03 | 665 | 107 | 8 | EFO_0007993 | |
| Disease | serum IgG glycosylation measurement | 3.00e-03 | 523 | 107 | 7 | EFO_0005193 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ASPTLGAPFACDFEQ | 56 | Q6UXC1 | |
| FPACSFAPAAAPQAV | 246 | Q96EY9 | |
| PPCPQDFSLNFDRAF | 41 | P49682 | |
| GCVPFLEQPAAAFVR | 521 | P48751 | |
| QAVLNRAFFPCFDTP | 171 | Q9H4A4 | |
| LFQPSFEICPFESEL | 546 | O94812 | |
| FFQPLDGFPSCVVTS | 456 | Q8NHY0 | |
| FRCPEAIFQPSFLGI | 256 | Q562R1 | |
| GDFVSCIFPVPQLFD | 151 | Q07092 | |
| AEACFSLPFFAPLGL | 171 | Q96QA5 | |
| VCLFEFLTGIPPFND | 766 | Q96GX5 | |
| FDFCPSVSEELPLFV | 11 | Q6XZF7 | |
| ASQLEPTFARYVFPC | 236 | Q6Q4G3 | |
| VCEPEALFSLAFPDN | 421 | P43268 | |
| LNTTCPFCGNIFLPF | 1476 | Q7Z401 | |
| TVPQFPRACTEAEFA | 191 | P98160 | |
| AVCSDFFNKAVPPDV | 861 | Q75QN2 | |
| PVSEFLLICFPNFQS | 11 | Q8NGH8 | |
| LPVNGFSPESCQIFF | 86 | Q6ZW49 | |
| LPFFEIFVDAPLNIC | 141 | O95340 | |
| APSGTVPVLFCFSVF | 21 | Q96CN7 | |
| VPVLFCFSVFARPSS | 26 | Q96CN7 | |
| EFTATFFPQPTFCSV | 161 | Q04759 | |
| FVCAQCFRPFPEGLF | 41 | Q7Z4I7 | |
| EPFSVRNKPFFDICT | 406 | O60942 | |
| LAFECITGFRPFLPN | 211 | O14920 | |
| GVNFCPVLQVFFPFS | 166 | Q10469 | |
| ASFDDVFVDCLQPLP | 216 | Q8WWW8 | |
| SFPPVVDFCLLSDFI | 406 | Q8TC71 | |
| IIVFAACFLPDSSLP | 191 | Q86WG3 | |
| CEPSFFPFLNSQDAF | 711 | Q3V5L5 | |
| FAVDQLAFQSPLPVC | 561 | Q8N3Y1 | |
| FCPFSFPTQPVNLFN | 1111 | Q15154 | |
| LAFPPNAIIVFFYCS | 51 | A6NKB5 | |
| PNELDSFFCDLPRFI | 171 | Q8NGB9 | |
| PVTPSLVFLCFIFDG | 121 | Q6P2I7 | |
| PLTFFNPLFSGASCV | 676 | Q9H7Z3 | |
| AFPANAACFLGFEVA | 276 | O43772 | |
| ATQFEPLAARSAFPC | 291 | Q9UIQ6 | |
| CPVAFFSFAPLITAI | 761 | Q9BXB1 | |
| FPIFESNFVQFCPDI | 111 | Q6IPT2 | |
| GFFILNCPDLTPLAF | 331 | Q05C16 | |
| CVLPNSFPENFVFKT | 866 | Q07864 | |
| AFLCFTPIFLAPHFQ | 671 | Q9UKX5 | |
| FDQLLAFVEFSCKPP | 1361 | Q7Z3U7 | |
| PAFAIFKFVQSICAA | 386 | O43934 | |
| PDFLAILSPFSFEVC | 146 | P35410 | |
| SPFLPDLNFFAADSC | 301 | P14652 | |
| FSGDDFSCVAPNVPL | 1146 | Q13349 | |
| PVFEFFLICFPSFQS | 11 | P0C7T3 | |
| ILSASQPFAFNCTFP | 31 | Q9HB29 | |
| FAPLPENSVNFCFDS | 176 | Q711Q0 | |
| NPCNFPIEFYSLEFD | 1851 | Q4G0P3 | |
| CVAVALPFQLTPFLD | 471 | Q9P2D3 | |
| VCKFPSAFFQGPADL | 1546 | Q96BY6 | |
| ASLCPVFAVAHFFPL | 76 | O14842 | |
| PRAVAFQDCPVDLFF | 26 | P12109 | |
| QQPFLPPAACFFATA | 21 | P50553 | |
| PKICPADPAFFSFIN | 191 | Q86TI2 | |
| FPNACIREAFLPEDS | 1946 | A8TX70 | |
| CPVFPTELAFALDTS | 2396 | P12111 | |
| FAALCPSFQIIAAPT | 766 | O15033 | |
| PSFFSISPQDCQFAL | 106 | P49641 | |
| SFCVAFPLAVGNPDL | 206 | Q9BZJ6 | |
| FTRDCFSEKPVPLNF | 106 | Q9NPI7 | |
| FSCVEPYTVPVFFNA | 366 | Q9UHC6 | |
| QNRPFFFACVPADSL | 7011 | Q8NDH2 | |
| LFCDPTFLPENDSLF | 26 | Q9Y6Q1 | |
| DQEILQSVPKFCFPF | 41 | Q6P3S1 | |
| QSVPKFCFPFDVERV | 46 | Q6P3S1 | |
| VPCSPSFAIDNFLCN | 3346 | Q9P225 | |
| FIFPFDYLPAEQVCT | 1871 | O75923 | |
| CTIAAATCFPEPFIN | 881 | Q08211 | |
| FYTACLDPNFPATLF | 51 | Q9UPX6 | |
| ICTNPLDTFFPFDPC | 551 | Q9NYV6 | |
| IFTQCPDGAFEAFPV | 126 | P35269 | |
| FGQPPCAFVTFRSAA | 106 | Q8IZ69 | |
| VESCFRLLVPFDFDP | 196 | Q2YD98 | |
| VAAFCPAFFEDPLGT | 631 | Q6ZMQ8 | |
| FVLSCLADQPPFFPE | 181 | O95255 | |
| GDPFTDLCFLNSPIF | 496 | Q5FBB7 | |
| VPRFCADHPFLFFIQ | 346 | P35237 | |
| SNPACLVNVLFFFTP | 21 | A0A5F9ZH02 | |
| EINSADFVFRCNLPP | 181 | O15466 | |
| PLDFTFVCPTEIVAF | 101 | P30048 | |
| PPAFDLFEAFAKVIC | 166 | Q9H7B4 | |
| FEALFITSHAFPCPV | 351 | Q8NHS4 | |
| LAEAPVPEEFAFAIC | 76 | Q6ICB4 | |
| QGPALCFAAAIFSLF | 191 | Q9BSA9 | |
| SPDFLCALAATVFPF | 1891 | Q8IZQ1 | |
| CALAATVFPFNIRPY | 1896 | Q8IZQ1 | |
| PDTDVFLACFSVVQP | 101 | Q96L33 | |
| QPFRDKCEPVFLFSV | 76 | Q8N427 | |
| LCFIFTVTDVFPPDS | 326 | Q9UGH3 | |
| ICFALVFLLPAAVFP | 441 | Q9UBY0 | |
| FPVAVICLFLNTFVP | 51 | Q69YW2 | |
| EFPDLFSEQLCSSFP | 41 | Q12772 | |
| LYTFDVAFAQPVCPT | 626 | O15344 | |
| FTCGEAFPAPTDLLQ | 181 | Q7Z340 | |
| TFNPEACFKDPSFLQ | 1441 | O60281 | |
| FYNNETFPSVLDPCL | 636 | Q96DN2 | |
| CPFEDFVFPPSVSEN | 3671 | Q709C8 | |
| IAPSVPFAANCFELF | 356 | Q9BWV7 | |
| PFAANCFELFGFDIL | 361 | Q9BWV7 | |
| SLETPKNPIAFACFF | 216 | Q9H0V1 | |
| FCELVFQLPFFPIAT | 71 | Q5BJF2 | |
| TTFSFFPPFVSCIQD | 2846 | P78527 | |
| APGSFRLDAPFCAAV | 1066 | Q8N398 | |
| FPASRIFSQCDLFPE | 71 | Q8WU66 | |
| ELRCTFCPFATFNPV | 371 | P52746 | |
| RFVPFPAVASANICN | 201 | Q8TD22 | |
| FSLDPEPIAINCTAF | 556 | A4D1P6 | |
| VPATCEPIQSVFFFS | 426 | P04004 | |
| NKINCVAAVFSAPPF | 891 | Q9NYI0 | |
| PVALFPSLCEFVFHN | 391 | Q6P2D8 | |
| ITPPCFNLFALFDAQ | 66 | P29597 | |
| FDPFQLIPCNFFSEE | 556 | Q5VVJ2 |